An XBP-1 dependent bottle-neck in production of IgG subtype antibodies in chemically defined serum-free Chinese hamster ovary (CHO) fed-batch processesBECKER, Eric; FLORIN, Lore; PFIZENMAIER, Klaus et al.Journal of biotechnology. 2008, Vol 135, Num 2, pp 217-223, issn 0168-1656, 7 p.Article

Construction of a bispecific single chain antibody for recruitment of cytotoxic T cells to the tumour stroma associated antigen fibroblast activation proteinWÜEST, Thomas; MOOSMAYER, Dieter; PFIZENMAIER, Klaus et al.Journal of biotechnology. 2001, Vol 92, Num 2, pp 159-168, issn 0168-1656Article

Evaluation of a combinatorial cell engineering approach to overcome apoptotic effects in XBP-1(s) expressing cellsBECKER, Eric; FLORIN, Lore; PFIZENMAIER, Klaus et al.Journal of biotechnology. 2010, Vol 146, Num 4, pp 198-206, issn 0168-1656, 9 p.Article

Human RERE is localized to nuclear promyelocytic leukemia oncogenic domains and enhances apoptosisWAERNER, Thomas; GARDELLIN, Paola; PFIZENMAIER, Klaus et al.Cell growth and differentiation. 2001, Vol 12, Num 4, pp 201-210, issn 1044-9523Article

Target-selective activation of a TNF prodrug by urokinase-type plasminogen activator (uPA) mediated proteolytic processing at the cell surfaceGERSPACH, Jeannette; NEMETH, Julia; MUNKEL, Sabine et al.Cancer immunology and immunotherapy. 2006, Vol 55, Num 12, pp 1590-1600, issn 0340-7004, 11 p.Article

A Humanized Tumor Necrosis Factor Receptor 1 (TNFR1)-specific Antagonistic Antibody for Selective Inhibition of Tumor Necrosis Factor (TNF) ActionKONTERMANN, Roland E; MÜNKEL, Sabine; NEUMEYER, Jens et al.Journal of immunotherapy (1997). 2008, Vol 31, Num 3, pp 225-234, issn 1524-9557, 10 p.Article

Protein Kinase D Regulates Cell Migration by Direct Phosphorylation of the Cofilin Phosphatase Slingshot 1 LikePETERBURS, Philipp; HEERING, Johanna; LINK, Gisela et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 14, pp 5634-5638, issn 0008-5472, 5 p.Article

A CD40-CD95L fusion protein interferes with CD40L-induced prosurvival signaling and allows membrane CD40L-restricted activation of CD95ASSOHOU-LUTY, Constance; GERSPACH, Jeanette; SIEGMUND, Daniela et al.Journal of molecular medicine (Berlin. Print). 2006, Vol 84, Num 9, pp 785-797, issn 0946-2716, 13 p.Article

Human antibody derivatives against the fibroblast activation protein for tumor stroma targeting of carcinomasMERSMANN, Michael; SCHMIDT, Alexej; RIPPMANN, Jörg F et al.International journal of cancer. 2001, Vol 92, Num 2, pp 240-248, issn 0020-7136Article

A novel functional polymorphism in the Transforming growth factor-β₂ gene promoter and tumor progression in breast cancerBEISNER, Julia; BUCK, Miriam B; FRITZ, Peter et al.Cancer research (Baltimore). 2006, Vol 66, Num 15, pp 7554-7561, issn 0008-5472, 8 p.Article

Antiestrogens Induce Transforming Growth Factor β―Mediated Immunosuppression in Breast CancerJOFFROY, Christian M; BUCK, Miriam B; STOPE, Matthias B et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 4, pp 1314-1322, issn 0008-5472, 9 p.Article

Targeted lipid-coated nanoparticles: Delivery of tumor necrosis factor-functionalized particles to tumor cellsMESSERSCHMIDT, Sylvia K. E; MUSYANOVYCH, Anna; ALTVATER, Martin et al.Journal of controlled release. 2009, Vol 137, Num 1, pp 69-77, issn 0168-3659, 9 p.Article

Differential activation of TRAIL-R1 and -2 by soluble and membrane TRAIL allows selective surface antigen-directed activation of TRAIL-R2 by a soluble TRAIL derivativeWAJANT, Harald; MOOSMAYER, Dieter; WÜEST, Thomas et al.Oncogene (Basingstoke). 2001, Vol 20, Num 30, pp 4101-4106, issn 0950-9232Article